PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Commercially viable product ready for FDA PIVOTAL trial

Yes it's a unique technology that was ahead of its time 20 years ago and it's time has come

Unique because it can be frozen and transported unlike other encapsulations.

And it's even better now than it was back then because it's been refined and improved by Austrianova.

The first clinical trials were impressive. Just wait till you see what it can do now with multiple treatments and measured with the huge improvements in imaging.

Novo nordisk and j&j are wanting to encapsulate beta and islet cells but Mellingen cells last longer and are superior and can be generated in the lab.

We have the superior product. Let's hope our CEO knows how to sell it.